Radcliff Family Chiropractic is now accepting appointments for Erchonia’s new FX 635 laser treatment for the relief of chronic low back pain. The FDA-approved, non-invasive FX 635 laser is proven to significantly reduce heel pain from plantar fasciitis in just three weeks.
Dr. Radcliff comments, “Low back pain can be extremely painful and persistent. Erchonia’s FX 635 laser is ideal for chronic low back pain sufferers, because it offers effective, pain-free treatment—without side effects. In just weeks, patients can have significant and lasting relief from low back pain and we can further battle the opioid crisis.”
Erchonia’s FX 635 laser received FDA-clearance based on a double-blind, randomized, multi-site and placebo-controlled clinical trial. Almost all patients treated with the FX 635 laser noted a dramatic reduction in pain and an improvement in function, with results far better than NSAIDS or Opioids.
For Chronic Back Pain
First and Only Chronic Low Back Pain Laser.
Discover the only laser on the market for the treatment of chronic low back pain. Our new FDA market cleared laser has been proven in double-blind, placebo-controlled, randomized, parallel group, multi-center clinical trial to effectively treat this painful condition. The participants of the FX 635 Clinical Trial showed a 58% pain reduction at 2 month follow-up evaluation. This trial went on to demonstrate that the FX 635 is successful in the treatment of chronic low back pain. The recent clearance of the FX 635 is groundbreaking for the pain management community and the war on opioids.
For Heel Pain
Discover the fastest way to treat Plantar Fasciitis
Now you can relieve the pain and inflammation of the heel associated with plantar fasciitis. Our new FDA market cleared laser has been proven in clinical tests to effectively treat this painful condition. The healing powers of this low level laser technology can reduce inflammation and eliminate pain in the plantar fascia in only a matter of weeks and return your patients to an active life once again.